Imfinzi 120 mg/2.4 ml
Imfinzi 120 mg/2.4 ml is a medicine authorised by Swissmedic under authorisation number 66548. The authorisation holder is AstraZeneca AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 11 June 2018 and the authorisation is valid without a time limit. ATC code L01FF03 places the medicine in the group Antineoplastic agents.
| Authorisation number | 66548 |
|---|---|
| Name | Imfinzi 120 mg/2.4 ml |
| Full name | Imfinzi 120 mg/2.4 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | AstraZeneca AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FF03 |
| First authorisation | 11 June 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Imfinzi 120 mg/2.4 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 11 June 2018 |
| 2 | Imfinzi 500 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 11 June 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FF03 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01FF03 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Imfinzi 120 mg/2.4 ml authorised in Switzerland?
Yes. Imfinzi 120 mg/2.4 ml is authorised by Swissmedic under authorisation number 66548, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Imfinzi 120 mg/2.4 ml have?
Imfinzi 120 mg/2.4 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Imfinzi 120 mg/2.4 ml?
The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.